Latest Orthocell (ASX:OCC) News
Page 3
Page 3 of 6
Orthocell Executes First Remplir Surgery in US Military Hospital Network Post-Approval
17 Apr 2026
Orthocell Gains U.S. Defence Network Approval for Remplir™ Nerve Repair Device
15 Apr 2026
Healthcare Wrap - Week 11 (9 Mar -> 13 Mar) 2026
14 Mar 2026
Orthocell Secures Exclusive UK Distributor for $750m Remplir™ Launch
10 Mar 2026
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
Orthocell Surges with Record H1 Revenue and Rapid US Expansion
24 Feb 2026
Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026
Orthocell Boosts Cash Reserves by $3M to Accelerate Remplir™ Rollout
18 Feb 2026
Healthcare Wrap - Week 6 (2 Feb -> 6 Feb) 2026
7 Feb 2026
Orthocell Accelerates US Rollout of Remplir, Eyeing Cash Breakeven Below 1% Market Share
2 Feb 2026
Healthcare Wrap - Week 4 (19 Jan -> 23 Jan) 2026
25 Jan 2026
Orthocell’s Remplir Drives Seventh Straight Quarter of Record Revenue
19 Jan 2026